The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Axsome Therapeutics Inc COM 05464T104 41,492 1,611,329 SH   SOLE   1,611,329 0 0
Bellerophon Therapeutics COM 078771102 1,450 2,417,227 SH   SOLE   2,417,227 0 0
BioCryst Pharmaceuticals Inc COM 09058V103 10,264 2,708,207 SH   SOLE   2,708,207 0 0
Constellation Pharmaceuticals COM 210373106 819 66,667 SH   SOLE   66,667 0 0
Gemphire Therapeutics COM 36870A108 646 798,066 SH   SOLE   798,066 0 0
Kadmon Holdings Inc. COM 48283N106 870 422,141 SH   SOLE   422,141 0 0
Kalvista Pharmaceuticals COM 483497103 14,129 637,884 SH   SOLE   637,884 0 0
Kiniksa Pharmaceuticals Ltd COM G5269C101 4,229 312,320 SH   SOLE   312,320 0 0
La Jolla Pharmaceuticals COM 503459604 11,580 1,251,898 SH   SOLE   1,251,898 0 0
Marinus Pharmaceuticals Inc COM 56854Q101 5,225 1,258,964 SH   SOLE   1,258,964 0 0
Milestone Pharmaceuticals Inc COM 59935V107 56,106 2,066,529 SH   SOLE   2,066,529 0 0
Obseva SA COM H5861P103 13,117 1,159,789 SH   SOLE   1,159,789 0 0
Orchard RX Ltd COM 68570P101 9,461 676,252 SH   SOLE   676,252 0 0
Protagonist Therapeutics Inc COM 74366E102 12,986 1,072,348 SH   SOLE   1,072,348 0 0
Proteostasis Therapeutics Inc COM 74373B109 216 221,267 SH   SOLE   221,267 0 0
Ra Pharmaceuticals COM 74933V108 20,157 670,350 SH   SOLE   670,350 0 0
Tricida Inc COM 89610F101 11,433 289,746 SH   SOLE   289,746 0 0